• 1.jpg
  • 2.jpg
  • 4.jpg
  • 5.jpg
  • 6.jpg
  • 7.jpg
  • DSCF6103.jpg
  • DSCF6330.jpg
  • DSCF6361.jpg
  • DSCF6682.jpg
  • DSCF7352.jpg
  • DSCF7463.jpg
  • DSCF7655.jpg
  • DSCF7700.jpg
  • DSCF7758.jpg
  • DSCF7761.jpg
  • 8.jpg
  • 9.jpg


pdf2FINAL PROGRAMME - 10 Years CLINAM
Ongoing poster submission (see page 27)

Under the Auspices of the Swiss Confederation and in Collaboration with 31 Organizations

colab4

 

Conference Venue:

Messeplatz 21
CH-4058 Basel, Switzerland
Phone +41 58 206 28 28 
This email address is being protected from spambots. You need JavaScript enabled to view it.

Organizers Office:
European Foundation for
Clinical Nanomedicine
Alemannengasse 12
CH-4016 Basel, Switzerland
Phone +41 61 695 93 95 
This email address is being protected from spambots. You need JavaScript enabled to view it.

Registration Office:
Organizers Schweiz GmbH
CLINAM 10/2017
Obere Egg
CH-4312 Magden, Switzerland
Phone +41 61 836 98 78 
This email address is being protected from spambots. You need JavaScript enabled to view it.

Basel, Switzerland:
https://en.wikipedia.org/wiki/Basel

 

Scientific Committee

• Prof. Dr. med. Patrick Hunziker, University Hospital Basel (CH) (chairman)

• Prof. Dr. med. Christoph Alexiou, University Hospital Erlangen (D)

• Prof. Dr. Lajos Balogh, Chinese Academy of Sciences, North Andover, MA (USA)

• Prof. Dr. Gerd Binnig, Nobel Laureate, Munich (D)

• Prof. Dr. Yechezkel Barenholz, Hebrew University, Hadassah MedicalSchool, Jerusalem (IL)

• Prof. Dr. med. Omid Farokhzad, Director, Center for Nanomedicine, Harvard Medical School and Brigham and Women's Hospital, Boston (USA)

• Prof. Dr. med. Dong Soo Lee, PhD. Chairman, Department of Nuclear Medicine Seoul National University (KOR)

• Dr. med. h.c. Beat Löffler, MA, CEO, CLINAM‐Foundation, Basel (CH) (programme)

• Prof. Dr. med. Marisa Papaluca Amati, European Medicines Agency, London(UK)

• Prof. Dr. Gert Storm, Institute for Pharmaceutical Sciences, Utrecht University, (NL)

• Prof. Dr. Viola Vogel, Laboratory for Biologically Oriented Materials, ETH, Zürich (CH)

Welcome to the European & Global Summit for Nanomedicine and Targeted Medicine. The goal of the CLINAM Foundation is to contribute to the benefit of patients and society by exploring and translating leading edge technologies towards clinical application, with an emphasis on Nanomedicine, Targeted Medicine and Precision Medicine. The summit keeps its tradition to build bridges from the enabling technologies to clinical application for major and neglected diseases. There is broad support for this summit by more than 30 collaborating non‐profit institutions.


Introduction

This is the 10th Summit of its kind. The CLINAM Foundation uses the opportunity of this Jubilee to present a programme with a strong focus on the route of nanomedicine – from basic and enabling sciences to successful clinical applications in targeted and precision medicine and related fields. We discuss critically common bottlenecks based on the experience of the past decade by our broad international expert community. Over the past decade, the CLINAM Summit evolved to an exquisite and globally unique event that brings together all stakeholders in Nanomedicine and Targeted Medicine. It builds on the principle that fundamental scientists, developers and professionals in clinical application and all to Nanomedicine related persons can mutually learn from each other to find better solutions for the medicine of the future. Based on recent groundbreaking achievements, the meeting will be a highlight. Emphasis is given on

• The scientific basis of nanomedicine
• New developments in analytic and diagnostic technologies
• Targeting and personalization
• Improved understanding of the mechanisms of nano interacting with life
• Pitfalls of nano in medicine
• The impact of digital technologies and modeling on nanomedicine
• Experimental and clinical application, digital technologies and modeling on nanomedicine
• Nanomedical immunotherapies
• The pathway to safe nanomedicines, to enable breakthroughs in successful clinical applications
• The entrepreneurial pathways for nanomedicine
• Plenary sessions highlighting the most recent and provocative developments
• Relevant issues in four Satellite Meetings:
Session 15. Arthritis Nanomedicine
Session 16. EU‐NCL European Nanomedicine Characterization Laboratory ‐ Lessons learned
Session 22. Global Regulatory Authorities and Related Parties Meeting
Session 34. Advancing the Development of New Medicines: Education and Workforce Training Partnerships

The last Weeks for Registration ‐ Meet the Pioneers in the Field

 

 

 


 The Foundation

The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing medicine to the benefit of individuals and society through the application of nanoscience. Aiming at prevention, diagnosis, and therapy through nanomedicine as well as at exploration of its implications, the Foundation reaches its goals through support of clinically focussed research and of interaction and information flow between clinicians, researchers, the public, and other stakeholders. The recognition of the large future impact of nanoscience on medicine and the observed rapid advance of medical applications of nanoscience have been the main reasons for the creation of the Foundation.

Nanotechnology for Medicine

Nanotechnology is generally considered as the key technology of the 21st century. It is an interdisciplinary scientific field focusing on methods, materials, and tools on the nanometer scale, i.e. one millionth of a millimeter. The application of this science to medicine seeks to benefit patients by providing prevention, early diagnosis, and effective treatment for prevalent, for disabling, and for currently incurable medical conditions.